July 3, 2025
We are pleased to share that CEO.ca has issued a press release as part of its latest Inside the Boardroom series, featuring Rapid Dose Therapeutics. In June, QuickStrip™ by Rapid Dose Therapeutics was featured in RecoverCann’s WGY6 campaign for Men’s Mental Health and PTSD Awareness...
July 3, 2025
BURLINGTON, Ontario – July 2, 2025 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE) announced today that as contemplated in the secured convertible notes (the “Notes”) previously issued on its private placement financing (the “Financing”), and consistent with prior quarters, the Company...
July 3, 2025
BURLINGTON, Ontario – June 27, 2025 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE) announces that it has agreed with its non-management directors (the “Directors”) to issue common shares (the “Debt Shares”) to such Directors in exchange for the cancellation of Director...
June 2, 2025
BURLINGTON, Ontario – May 30, 2025 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE) today announced that further to its press release dated May 10, 2025, it has entered into debt settlement agreements with certain of its creditors (the “Creditors”) to issue...
May 27, 2025
BURLINGTON, Ontario – May 27, 2025 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE) today announced that it plans to complete an equity private placement financing (the “Financing”) for up to $3,000,000 of gross proceeds, consisting of up to 13,636,364 units (the...
May 26, 2025
BURLINGTON, ON – May 26, 2025 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian life sciences company specializing in innovative drug delivery solutions through its QuickStrip™ platform, today announced the filing of two critical patent applications in partnership with Aavishkar...
May 15, 2025
The evolution of dental anesthesia is entering a new era with the introduction of LQS, Lidocaine QuickStrip™, a cutting-edge muco-adhesive oral thin film developed by Rapid Dose Therapeutics (RDT; CSE: DOSE) in partnership with Skycare Compounding Labs. Utilizing proprietary QuickStrip™ technology, LQS bridges the gap...
May 9, 2025
BURLINGTON, Ontario – May 09, 2025 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE) announces that it has agreed with certain of its creditors (the “Creditors”) to issue up to an aggregate of 2,500,000 common shares (the “Settlement Shares”) to such Creditors...
April 8, 2025
BURLINGTON, Ontario – April 8, 2025 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian biotech Company providing proprietary oral delivery platform via sublingual thin film strip technology, is proud to announce an update to the ongoing collaboration project with the...
April 3, 2025
BURLINGTON, Ontario – April 3, 2025 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian biotech Company providing proprietary oral delivery platform via sublingual thin film strip technology, is proud to announce its participation at major dental tradeshows across Canada to...